DV
Dividend Vision

BMRN — BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. (BMRN)

Total return is 413.2% over the past 27.1 years, 404.3 points behind SPY at 817.5%. Its deepest 1-year drawdown was 22.5%.

BMRN is a single-stock equity holding in BioMarin Pharmaceutical Inc., a biopharmaceutical company, rather than a diversified ETF. The holding does not currently pay distributions, making it unsuitable for income-focused investors seeking dividend yield. This security appeals primarily to growth-oriented investors interested in concentrated exposure to the biotechnology sector.

BMRN key facts

Asset type
Stock
Asset class
Equity
Inception date
07/23/1999
Distribution frequency
None
Last close
$67.36
Market cap
$13,039,128,576
Average volume
1413500.0
Beta
0.227
Payout ratio
0.0
P/E ratio
187.1111
Forward P/E
14.0056
EPS
$0.36